Tuesday, April 7, 2020

Ligand Buys Assets From Icagen

San Diego-based Ligand Pharmaceuticals said last week that it has completed its $15M cash acquisition of the core assets of Icagen's North Carolina operations. Ligand Pharmaceuticals said it acquired the core assets, partnered programs, and ion channel technologies from Icagen. In addition to the $15M in cash, Ligand said that Icagen is entitled to

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---